# Blood Spot and Urine Metabolomic Screening Applied to Rare Diseases

> **NCT06360913** · NA · RECRUITING · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 2286 (estimated)

## Conditions studied

- Inborn Errors of Metabolism
- Rare Diseases

## Interventions

- **DIAGNOSTIC_TEST:** High resolution mass spectrometry

## Key facts

- **NCT ID:** NCT06360913
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-03
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 2286 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360913, "Blood Spot and Urine Metabolomic Screening Applied to Rare Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06360913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*